Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers.
about
Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresisInvestigations with O-linked protein glycosylations by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry.Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes.Development of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patientsOvarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines.Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX.Multiplex Immunosensor Arrays for Electrochemical Detection of Cancer Biomarker Proteins.Ultrasensitive electrochemical immunosensor for oral cancer biomarker IL-6 using carbon nanotube forest electrodes and multilabel amplification.The effects of abundant plasma protein depletion on global glycan profiling using nanoLC FT-ICR mass spectrometry.Molecular genetics complexity impeding research progress in breast and ovarian cancers.A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissueQuantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum.Single-wall carbon nanotube forest arrays for immunoelectrochemical measurement of four protein biomarkers for prostate cancer.Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform.Multi-peptide nLC-PC-IDMS-SRM-based assay for the quantification of biomarkers in the chicken ovarian cancer modelMeasurement of biomarker proteins for point-of-care early detection and monitoring of cancerConfounding effects of hormone replacement therapy in protein biomarker studies.Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum.Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma.Mass spectrometry-based biomarker discovery: toward a global proteome index of individualityFunctionalized polymeric nanoparticles loaded with indocyanine green as theranostic materials for targeted molecular near infrared fluorescence imaging and photothermal destruction of ovarian cancer cells.Impact of post-operative hormone replacement therapy on life quality and prognosis in patients with ovarian malignancy.Nanomaterials-based electrochemical immunosensors for proteins.Ion mobility-mass spectrometry analysis of serum N-linked glycans from esophageal adenocarcinoma phenotypesProteomic contributions to personalized cancer care.Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer.Absolute quantification of C-reactive protein in human plasma derived from patients with epithelial ovarian cancer utilizing protein cleavage isotope dilution mass spectrometryUltrasensitive immunosensor for cancer biomarker proteins using gold nanoparticle film electrodes and multienzyme-particle amplification.Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.Electrochemical Immunosensors for Interleukin-6. Comparison of Carbon Nanotube Forest and Gold Nanoparticle platforms.Designing nanomaterial-enhanced electrochemical immunosensors for cancer biomarker proteinsProfile of native N-linked glycan structures from human serum using high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry.Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation.Expression of Semaphorin 3F and Its Receptors in Epithelial Ovarian Cancer, Fallopian Tubes, and Secondary Müllerian Tissues.In-depth LC-MS/MS analysis of the chicken ovarian cancer proteome reveals conserved and novel differentially regulated proteins in humansMiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2.Tumor markers for early detection of ovarian cancer.Gold and iron oxide hybrid nanocomposite materials.Multifunctional superparamagnetic iron oxide nanoparticles: design, synthesis and biomedical photonic applications.
P2860
Q24600418-AF82CEAD-EF15-41CB-8A25-7C3310BBB66BQ33322900-9B94CE47-0E45-4C5E-B040-AA62D64B309DQ33361745-C2B8D8D5-2743-4BC3-9CD6-8A165AA49FEEQ33396321-8E2FE1D6-050C-4E7E-99B1-764BDF369AF5Q33495701-D4671D2C-9FB5-4B5A-95C3-94B9A25C21E7Q33514817-F90E981F-DCB9-4902-A628-CAC40381A6CCQ33745022-0AFC4223-4946-4422-907B-F5DEB720545AQ33764870-92793EAB-4AF9-432A-958E-A6C6680805E0Q33790362-570D3656-C639-4FAA-B28E-FF1AFBC50AECQ33836040-17C31D6B-0ED2-47B7-B47F-FED9363E61FFQ33858073-8B870BA5-36C5-4182-86A9-1BF0CE0AAE0FQ33889245-F9861021-23FE-4AE0-951C-8075D7108FB4Q33945104-0BD24B71-58D3-4A57-A6E6-5C96458F583DQ33982421-9861D4ED-B96A-429A-BDB4-035C230AB5B3Q34142972-D807B89A-71A8-4EF0-9119-BFD4EFFDE57FQ34180244-74D99529-F18B-4C0A-AB7A-693DDCCCD549Q34384187-860DF7A9-5158-47C8-A0C7-0C5B6543A692Q35051095-F5D46C57-184C-4DD9-8D9C-0F98DB4F1946Q35061782-F1A16FD6-2BED-460E-AD3B-178354087CA5Q35118218-F399B44D-9586-46D3-BF04-190DB5050422Q35118223-2412AE15-324F-4180-AA77-08E92B64D001Q35194188-AE9C0B25-4E0E-4BCA-BCF8-DDC17B32FF6EQ35995593-3BF0553F-7226-4E44-A5C6-CBDDF4E6DB65Q36026655-8763F4E3-CBCD-4A34-8511-0F42467660ACQ36501921-03D46095-B537-4172-B243-CB5E116D9C05Q36920002-0D30598C-F6AE-4AA5-89BB-110D5383D170Q37068001-058AB852-60C3-4A77-924D-D4F6A8B5545AQ37087593-05B90FB3-6A84-43F9-BCE7-9236D325CEB5Q37153497-F9157349-581B-426D-A3ED-FD175F0992A5Q37317324-0DC19B75-2EFF-45FA-AB1F-0B15EA8AA1D9Q37326740-059626D1-0073-404F-B23C-18187DCE7412Q37347564-4D21C639-5275-414F-8D30-C2D359ACA07AQ37396485-8E7E3DCF-8C9E-48B9-B9E1-A6EFE456D8ADQ37414190-7BE1B7B0-4679-45A0-802F-DADFBA9CDD6AQ37484796-409C6F9D-45E7-4DFC-87D2-2D4EB8CDBFB1Q37607036-A0D4A9FB-E621-4F27-B640-7D403A300E22Q37619736-2480BCE1-E4D1-4768-B1DA-C5EF0A1D6D68Q37789033-7B56BD8A-44B8-4725-BACB-2A390D249925Q37950832-02F711B8-9F61-4DC7-A00E-6C131C37A7A8Q38123354-5AA7278D-56EF-401B-B8EF-B8601A884FB7
P2860
Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Epithelial ovarian cancer: dis ...... olite, and protein biomarkers.
@en
type
label
Epithelial ovarian cancer: dis ...... olite, and protein biomarkers.
@en
prefLabel
Epithelial ovarian cancer: dis ...... olite, and protein biomarkers.
@en
P2093
P356
P1476
Epithelial ovarian cancer: dis ...... olite, and protein biomarkers.
@en
P2093
David C Muddiman
Diana A Saggese
Kimberly R Kalli
Kristina L Toups
Taufika Islam Williams
William A Cliby
P304
P356
10.1021/PR070041V
P577
2007-06-21T00:00:00Z